PHI Group Regional Center Files Application with USCIS for EB5 Immigration Investor Program

PHI Group Regional Center Files Application with USCIS for EB5 Immigration Investor Program

EB-5 Visa, EB5 Visa, EB-5 Investment

PHI Group, Inc., a company focused on acquisitions and investments in natural resources, energy, agriculture and special situations announced today that PHI Group Regional Center LLC has filed an application with the United States Citizenship and Immigration Service (USCIS) for the PHI Group EB5 Regional Center in Florida.

Under the EB-5 Program, created by Congress to stimulate the U.S. economy through job creation and capital investment, foreign entrepreneurs (and their spouses and unmarried children under 21) are eligible to apply for a Green Card (permanent residence) if they make the necessary investment in a commercial enterprise in the United States that creates or preserves at least 10 permanent, full-time jobs for qualified U.S. workers.

Since its inception in 1990, the EB-5 program has attracted at least $15 billion in investments ($4.2 billion in FY15 alone), created at least 77,150 American jobs and provided more than 44,400 visas to the United States. EB-5 program investors have helped finance a Hollywood movie studio, a New York sports arena, office parks in Texas and the FBI office building in San Diego, among hundreds of successful projects.  

The Company intends to raise $15 million and create 300 new full-time jobs through the PHI Group EB5 Regional Center during the first phase of its organic farming program and other business activities in Florida. PHI Group has opened an escrow account to acquire a farm in Holmes County, Florida, which includes 408 acres of land, buildings, barns, fixtures, certain equipment and water pumping rights for irrigation.  The Company also continues to look for new business opportunities in the U.S. and abroad that may potentially add significant shareholder value.

Abundant Farms, Inc., a subsidiary of PHI Group, plans to use a combination of proprietary enhanced bioavailable nutrient and natural symbiotic immune systems without chemical pesticides and synthetic fertilizers, to grow select plants that can be used for medicinal purposes including bitter melon (momordica charantia), turmeric (curcuma longa), Ming aralia (polyscias fruticosa) and others that command higher profit margins than regular vegetables. The Company has received indication of interest from an Asian buyer for $45 million worth of bitter melon product. Abundant Farms also plans to raise premium organic livestock and develop a model organic farming program, which can be replicated and licensed to other farmers on a global basis.

Henry Fahman, Chairman and CEO of PHI Group, stated, “We look forward to the approval of our EB-5 regional center application, which will not only allow qualified foreign investors to participate in our future growth and legally immigrate to the U.S. but also enable us to raise low-cost non-dilutive long-term capital that can be mutually beneficial.”


http://www.econotimes.com/PHI-Group-Regional-Center-Files-Application-with-USCIS-for-EB5-Immigration-Investor-Program-666417

Mentions

States

  • Nevada


Securities Disclaimer

This website is for informational purposes only and does not constitute an offer or solicitation to sell shares or securities. Any such offer or solicitation will be made only by means of an investment's confidential Offering Memorandum and in accordance with the terms of all applicable securities and other laws. This website does not constitute or form part of, and should not be construed as, any offer for sale or subscription of, or any invitation to offer to buy or subscribe for, any securities, nor should it or any part of it form the basis of, or be relied on in any connection with, any contract or commitment whatsoever. EB5Projects.com LLC and its affiliates expressly disclaim any and all responsibility for any direct or consequential loss or damage of any kind whatsoever arising directly or indirectly from: (i) reliance on any information contained in the website, (ii) any error, omission or inaccuracy in any such information or (iii) any action resulting therefrom.